S.A. Mason LLC Decreases Holdings in The Cigna Group (NYSE:CI)

S.A. Mason LLC lowered its position in The Cigna Group (NYSE:CI) by 7.0% in the 4th quarter, Holdings Channel reports. The institutional investor owned 2,631 shares of the health services provider’s stock after selling 199 shares during the period. S.A. Mason LLC’s holdings in The Cigna Group were worth $726,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. ORG Wealth Partners LLC bought a new position in shares of The Cigna Group during the 4th quarter valued at $34,000. Ulland Investment Advisors LLC boosted its holdings in The Cigna Group by 2,500.0% during the 3rd quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock valued at $36,000 after acquiring an additional 100 shares during the period. Prospera Private Wealth LLC bought a new position in The Cigna Group during the 3rd quarter worth approximately $37,000. Harbor Capital Advisors Inc. purchased a new position in The Cigna Group in the 3rd quarter worth approximately $45,000. Finally, Heck Capital Advisors LLC purchased a new stake in shares of The Cigna Group during the fourth quarter valued at approximately $53,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

CI has been the subject of several analyst reports. Barclays dropped their price target on shares of The Cigna Group from $420.00 to $339.00 and set an “overweight” rating for the company in a research report on Friday. StockNews.com cut The Cigna Group from a “buy” rating to a “hold” rating in a report on Friday. Stephens reduced their target price on The Cigna Group from $410.00 to $380.00 and set an “overweight” rating on the stock in a research note on Friday. Royal Bank of Canada cut their price target on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. Finally, Raymond James restated a “strong-buy” rating and issued a $360.00 price objective (down from $415.00) on shares of The Cigna Group in a report on Friday. Two research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $380.27.

The Cigna Group Trading Up 3.9 %

Shares of NYSE CI opened at $293.99 on Monday. The firm’s 50 day moving average price is $294.40 and its 200-day moving average price is $324.33. The Cigna Group has a 52-week low of $262.03 and a 52-week high of $370.83. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The company has a market cap of $81.77 billion, a PE ratio of 24.02, a P/E/G ratio of 0.97 and a beta of 0.54.

The Cigna Group (NYSE:CI) last posted its earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period in the prior year, the business posted $6.79 earnings per share. On average, equities research analysts expect that The Cigna Group will post 29.66 EPS for the current fiscal year.

The Cigna Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th will be given a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a yield of 2.05%. The ex-dividend date is Wednesday, March 5th. This is an increase from The Cigna Group’s previous quarterly dividend of $1.40. The Cigna Group’s payout ratio is 45.75%.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.